Gagandeep Kang

Gagandeep Kang vaccine the wire science

Covishield Blood Clot Risk Minuscule but Govt Not Transparent: Gagandeep Kang

Karan Thapar 09/04/2021

The country's top vaccine scientist told The Wire that...

800px-ROAD_INSIDE_KGMU

Lucknow: 40 Docs Test Positive For COVID-19 After Taking Vaccines

The Wire Staff 08/04/2021

Doctors are saying there may be reason to doubt...

Indian Health Minister Harsh Vardhan holds a dose of Bharat Biotech's COVID-19 vaccine, Covaxin, during a vaccination campaign at All India Institute of Medical Sciences (AIIMS) hospital in New Delhi.

India Has Exported 5.84 Crore Doses of COVID-19 Vaccines To 70 Countries: Data

The Wire Staff 17/03/2021

India has exported 2.36 crore doses of COVID-19 vaccines...

People enjoy the Ponta Negra beach along the Amazon river, amid concerns about the spread of the coronavirus disease (COVID-19) in Manaus, Brazil, September 6, 2020. REUTERS/Bruno Kelly/File Photo

Herd Immunity Difficult to Achieve: AIIMS Director Randeep Guleria

Variant strains and immunity changes over time can lead...

KT 17 Feb 2021.00_48_57_08.Still002 (1)

‘Delay Second Covishield Dose, Permit Open Market Sales for Unused Vaccines’

Karan Thapar 19/02/2021

In an interview with Karan Thapar for The Wire,...

Dr. Vinod K. Paul poses for a picture at his office in New Delhi

What Does Treating Covaxin and Covishield ‘Equally’ Entail?

Vasudevan Mukunth 15/01/2021

India's vaccine roll-out programme was initially premised on the...

Screen Shot 2021-01-05 at 6.31.26 PM

Watch | ‘Why Authorise a Vaccine Without Phase 3 Efficacy?’: Gagandeep Kang

Karan Thapar 06/01/2021

India’s top vaccine scientist says the process of approval...